Detailed Narrative
Record Q1 FY27 Performance Driven by Operational Excellence
Deepak Nitrite Limited delivered its highest-ever quarterly performance in Q1 FY27, with consolidated revenue from operations reaching ₹2,592 crore, marking a 35% year-on-year and 22% quarter-on-quarter growth. EBITDA surged by 159% YoY to ₹554 crore, with margins expanding to 21% from 11% in Q1 FY26. This robust growth was attributed to improved market conditions, enhanced customer engagement, and significant manufacturing efficiencies, alongside benefits from recently commissioned assets.
Phenolics Segment Achieves All-Time High Profitability
The Phenolics business recorded its highest-ever quarterly performance, with revenues increasing to ₹1,775 crore, up 36% YoY and 24% QoQ. EBIT for the segment reached a record ₹418 crore, a 254% YoY and 46% QoQ increase, resulting in an EBIT margin of 24%. This strong showing was supported by stable plant operations, innovative procurement strategies, and a robust domestic market position, enabling reliable customer deliveries and healthy profitability despite global feedstock volatility.
Advanced Intermediates Segment Shows Strong Growth and Integration Benefits
The Advanced Intermediates (AI) segment also reported a strong quarter, with revenues rising to ₹804 crore, representing a 33% YoY and 14% QoQ growth. EBIT for the segment improved by 89% YoY to ₹67 crore, achieving an 8% EBIT margin. Performance was boosted by improving domestic demand, a better product mix, and increasing synergies from recent backward integration initiatives, including the successful stabilization of the ammonia-to-amines integration chain, which enhances manufacturing flexibility and raw material security.
Strategic Capacity Expansion and New Project Commissioning
Deepak Nitrite is actively pursuing capacity expansion and new project commissioning. The company aims to debottleneck its phenol plant to achieve an annualized run rate of 4 lakh tonnes, with an additional investment of approximately ₹70 crore. Furthermore, the multipurpose agrochemical intermediates facility, along with MIBK, MIBC, and acetophenone projects, are on track for commissioning in August 2026, with other related projects expected within Q2 FY27, promising to strengthen downstream integration and expand the product basket.
Polycarbonate Project Progress and Financial Structuring
The company's first integrated polycarbonate project, a significant ₹11,500 crore investment, continues to progress as per its execution roadmap. The project is being funded with a 60:40 debt-to-equity ratio, with the entire debt tied up at competitive rates. Management anticipates peak debt to be between ₹8,000 crore and ₹8,500 crore, ensuring the debt-to-equity ratio will not exceed 1, maintaining a comfortable capital structure. The polycarbonate (H2) commissioning is targeted for FY28-29, followed by BPA a couple of months later.
R&D Focus on Value-Added Products and Process Innovation
Deepak Nitrite's R&D platform is robust, with several products across fluorination, amination, nitration, and specialty chemistries progressing through customer qualifications. The company is focusing on developing new molecules and applications with better purity profiles to drive margin improvement, moving beyond historical 'red ocean' competition. Innovations in flow chemistry, such as reducing production time from 16-18 hours to 45-52 seconds for certain products, are enhancing efficiency and reducing hazardous intermediates.
Capital Expenditure Plans for FY27 and Beyond
The company has already spent ₹1,200 crore on capital expenditure. For the remainder of FY27, an additional ₹1,000 crore to ₹1,500 crore is planned, bringing the total cumulative spend to approximately ₹3,200 crore. Looking ahead to FY28 and FY29 (2027-2028), the company plans to spend another ₹3,000 crore, primarily on site development, construction, and setting up assets from outside India, supporting its long-term growth initiatives.